The effects of tumour cells (Colon 26) on the development and response of new blood vessels to different vasoconstrictors (platelet activating factor; PAF, endothelin-1, angiotensin II, adrenalin and 5-hydroxytryptamine) have been investigated. Sponge implants in mice were used to host tumour cells while washout of '33Xe was employed to assess local blood flow in the implanted sponges.
Tumour angiogenesis, the formation of capillary vessels induced by neoplastic cells with eventual development of a functional microcirculatory network within the growing mass, is a process analogous to the formation of capillary vessels in granulation tissue during wound repair (Warren, 1979) . Morphological abnormalities in vessels in either situation have frequently been reported (Schoelfl, 1963; Warren, 1979; Jain 1988; Vaupel et al., 1989) . However, compared to other angiogenic stimuli, tumours induce a very intense and persistent response (Folkman & Klagsbrun, 1987) so that more severe abnormalities may be observed in tumour vessels; this tendency is accentuated in rapidly growing neoplasms (Vaupel et al., 1989) . Pharmacological as well as anatomical abnormalities have been documented in tumour blood vessels, though the situation is far from clear-cut. Thus, experimental studies have suggested either increased (Young et al., 1979; Tveit et al., 1981) , similar (Mattsson et al., 1982) or decreased (Wickersham et al., 1977) sensitivity to vasoactive stimuli in the tumour vascular bed compared to normal tissue. These differences have been attributed to the transplantation area of the tumour, the type of tumour and the different techniques used for measuring blood flow (Suzuki et al., 1984) . The washout of locally injected radioactive '33Xe (Peterson, 1979) has been shown to be a reliable index of tumour blood flow when applied to relatively small, superficially located cancers (Kallman et al., 1972) . This technique has also been used for examining the influence of vasoactive drugs on local blood flow in tumours and normal subcutaneous tissue (Mattsson et al., 1980; 1982) . Previously we have used washout of '33Xe to show a temporal progression in blood flow and functional characteristics of newly formed blood vessels within subcutaneous granulation tissue in sponge implants in rats and in mice (Andrade et al., 1987; Andrade et al., 1991) .
Sponge implants provide a physically well defined in vivo compartment particularly useful for investigating the changes that accompany ingrowth of vascularised connective tissue. The sponge has also been used as a framework to host different tumour cell lines in rodents (Thiede et al., 1988; Mahadevan & Hart, 1991) which permits the analysis of newly formed tumour blood vessels. In this paper, using our sponge implant system to host Colon 26 tumours and washout of '33Xe to assess local blood flow in the implanted sponges, we have studied the angiogenic effects of an adenocarcinoma on neovascularisation of sponge implants in Balb/c mice and on the pharmacological responses of the newly formed vessels.
Material and methods

Animals
Adult male Balb/c mice weighing 20-28 g were used for all experiments.
Sponge implants Polyether-polyurethane sponge discs, 4 mm height x 8 mm diameter (Vitafoam Ltd., Manchester, UK) were used as the matrix to host tumour cells and to monitor for angiogenesis. One end of a polythene tubing 1.2 cm long x 1.2 mm internal diameter (Portex Ltd., Hythe, Kent, UK) was secured to the centre of each disc with two 5/0 silk sutures (Ethicon Ltd., UK) so that the tube was perpendicular to the disc face. The sponge discs with cannula attached were soaked overnight in 70% v/v ethanol and sterilised by boiling in distilled water for 15 min.
Implantation of sponges Discs were implanted using aseptic techniques in mice anaesthetised by intramuscular injection of Hypnorm and Hypnovel (0.5 ml kg-' of each). The dorsal hair was shaved and the skin wiped with 70% ethanol. A 1 cm mid-line incision was made and through it one subcutaneous pocket was prepared by blunt dissection. A sterilised sponge implant was then inserted in the pocket, its cannula being pushed through a small incision which had been made previously on the top of the pocket. The base of the cannula was sutured to the skin. The cannula was then plugged with a smaller piece of sealed polythene tubing. The mid-line incision was closed by 2-3 silk sutures and the animals were housed singly with free access to food and water. Establishment of tumour-bearing implants Colon 26 cells (Tsuro et al., 1983) were cultured in Dulbecco's modification of Eagle's essential medium supplemented with 10% foetal bovine serum and 1% L-glutamine. Once confluent the monolayer was harvested by incubation for 2 min with trypsin/EDTA (0.025% and 0.02 w/v respectively). The dislodged cells were centrifuged for 10 min and adjusted to the appropriate concentration in saline; 50 LI of the cell suspension (1 x 106 cells) were injected into the sponges 2 days after their implantation. This procedure yielded a tumour take of 100% producing progressive growths which were visible around 10 and 12 days after cell injection (i.e. 12-14 days after sponge implantation).
Histological examination of implants At fixed times, mice were anaesthetised then killed by cervical dislocation and the sponge implants dissected free from subcutaneous tissue. The implants were fixed in formalin (10% w/v in isotonic saline) and transverse sections were cut (5 gm) from half way through the sponge's thickness. Identification of a-actin was achieved using streptavidin-peroxidase staining with a swine antibody to rabbit o-actin (1: 500) which crossreacts with murine a-actin. This contractile protein was demonstrated in cells within the walls of the blood vessels. Some sections were stained with haematoxylin and eosin (H&E).
Bloodflow measurement To determine of local blood flow in control and tumourbearing implants, the mice were anaesthetised with Hypnorm/Hypnovel as before and a 10 IlI bolus of 133Xe, containing 103 counts per s, was injected into the sponge implant via the cannula which was quickly plugged to prevent evaporation of the gas. The washout of the radioactive tracer was followed by external detection with a collimated gamma-scintillation detector (sodium iodide-thalium activated crystal; 1 inch by 1 inch) positioned 1 cm directly above the site of the injection. The radioactivity was accumulated for 40 s over 6 min after injection and the 40 s counts printed automatically on an SR7 scaler ratemeter (Nuclear Enterprises Ltd., London, UK). The rate of washout of 133Xe was expressed in terms of its half-time (tl/2; time taken for the radioactivity to fall to 50% of its original value).
Assessment ofpharmacological reactivity of newly formed blood vessels in control and tumour-bearing implants In any single implant, the untreated tl/2 value was measured following the injection of saline alone. Then 40 min later the tl/2 value was established following the administration of a specific vasoconstrictor. Up to three successive '3Xe washout assays, with 45 min intervals, were possible in one implant per day. At the end of the experimental session, the animal was kept warm until it had recovered fully from anaesthesia. Preliminary experiments showed that untreated tl/2 values were constant from day to day after day 8 (i.e. 6 days after cell injection) in the tumour-bearing implants and from day 10 for control implants; successive assays on the same day also gave constant tl/2 values.
Responses of the vessels to vasoconstrictors PAF (0.1, 0. (Figure 1) .
Responses of the vasculature in control and tumour-bearing animals The effects of a number of vasoconstrictors were measured firstly in normal skin. These results (Table I) showed that the doses used caused marked increases in tl/2 values as a consequence of vasoconstriction. The vasoconstrictors were then assessed for their effect on the vasculature in the implants. In the first set of such experiments, the vasomotor response to endothelin-1 was measured at day 10 postimplantation in both types of implant (i.e. 8 days after tumour cell injection in tumourbearing implants). The initial washout rate of "'Xe in control implants (7.8 ± 1 min; n = 4) was not different from that in tumour-bearing implants (6 ± 1 min; n = 4) under these conditions. After a bolus injection of endothelin-l (1.25 ng), blood flow in both implants decreased, i.e. tl/2 increased markedly, in both control and tumour-bearing implants (Figure 2) . However, at the later stage of 14 days postimplantation, the tl/2 values in untreated implants of either type were again equal (5.1 ± 0.7 min, control; 6 ± 1.6 min, tumour-bearing implant; n = 4), and the response to endothelin-l (1.25 ng) in control implants was marked by a substantial increase in tl/2 value (29 ± 3 min) but the tumour response was now substantially less than that seen at day 10, or that manifest by 14 day control sponge, with a tl/2 of 11 ± 1 min. (Figure 2) .
Because of this divergence between control and tumour vessel response, all subsequent tests of vasoreactivity were made in implants at 14 days. Figure 3 shows the blood flow in control implants and the blood flow in tumour-bearing implants in response to four different vasoconstrictors. Over a range of doses for each vasoconstrictor there was a response as shown by the increase in t 1/2 in the control implants. By contrast, the vessels in the tumour-bearing implants did not respond to PAF (0.1; 1 and 2 pg) or to low doses of endothelin-l, angiotensin II Significant responses were obtained at higher doses of the mediators but markedly less than in the control implants. Responses to 5-HT were generally similar in both control and tumour-bearing implants in that no significant differences in tl/2 values were recorded between the two groups at any of the doses used (Figure 3c ).
Discussion
Our results have confirmed the angiogenic effects of an adenocarcinoma cell line growing in subcutaneously implanted sponge discs (Mahadevan & Hart, 1991) . These implants provide a well-defined, initially avascular compartment for the growth of tumour cells. Neovascularisation of the implant was assessed by '33Xe washout and has been correlated with histological evidence of vessel growth (Andrade et al., 1987) ; the progressive fall in tl/2 reflected development of blood vessels in the implant. In the present experiments using this technique early changes in blood flow could be detected even before visible growth of the tumour mass was apparent.
The combination of sponge implant and '33Xe washout offers a valuable experimental opportunity to study the pro- Although the untreated tl/2 values were identical for control and tumour-bearing implants, the vasoconstrictor effects (increased tl/2) were consistently lower (angiotensin II, endothelin-l) or absent (PAF) in tumour-bearing implants. (Warren, 1979) . We have also observed that, in the absence of tumour cells, newly formed blood vessels infiltrating the sponge matrix exhibited features such as dilatation, tortuosity and saccular structure (Andrade unpublished results). All these features are apparent in tumour blood vessels (Jain, 1988; Vaupel et al., 1989) .
The method allows non-destructive repeated measurements of blood flow in the same animal over the period of neovascularisation of the implants; thus changes occurring during the development of normal or tumour vasculature may be followed in the same animals. Consequently we were able to demonstrate clearly that there was a change in vaso-reactivity to endothelin-1 between 10 and 14 days in the tumourbearing implants. A similar progressive loss in the capacity to react to vasoactive agents by blood vessels in experimental mammary tumours as the tumours enlarged was reported by Wickersham et al. (1977) . A possible explanation for the progressive loss of reactivity in tumour, but not control, implants could be that, unlike the vessels of inflammatory granulation tissue, tumour vessels are characterised by a steady progression to necrosis without any intervening stable maturation phase (Suzuki et al., 1984) . Another contributing factor could be that during neoplastic growth some of the preexisting host vessels incorporated in the tumour mass disintegrate, are obstructed or are compressed (Vaupel et al., 1989) .
At the 14 day time point decreased sensitivity in the tumour neovasculature relative to the age-matched control neovasculature was the predominant response to most of the vasoconstrictors used in our experiments. However one vasoconstrictor, 5-HT, elicited very similar responses in all of the three vascular beds examined (normal skin, control implants and tumour implants). A normal vasoconstrictor response to 5-HT also has been reported in subcutaneously implanted Meth-A tumours (Stucker et al., 1991) . Several studies have suggested that arteries and arterioles are resistant to neoplastic invasion (Intaglietta et al., 1977; Warren, 1979) . Possibly intact innervation and contractile elements may remain in normal blood vessels incorporated in the invading tumour mass, thus maintaining the ability to respond to serotoninergic agonists. A weak response was obtained to angiotensin II and adrenalin in neoplastic tissue only after administration of a dose 10-100 fold greater than that which evoked a response in the control neovasculature. Suzuki et al. (1984) observed that newly growing tumour vessels did not react to topically administered angiotensin II. The vessels supplying tumours have been reported to be relatively unreactive to locally applied drugs which act on smooth muscle (Hirst et al., 1991) . This lack of response might reflect a lack of structural strength, with tumour vessels having little smooth muscle and a poorly organised adventitia (Can et al., 1984) . Interestingly then our immunohistochemical studies failed to show any marked differences in actin content between control and tumourbearing implants (Figure 1 ). Though this assessment is, of necessity, crude it could suggest that decreased sensitivity in Colon 26 tissue is not due to a lack of contractile elements in tumour blood vessels. Perhaps other factors could contribute to the differences observed in our system. For example, tumour vascular endothelium possesses immature cell contacts within the endothelial lining of the vessel wall (Warren, 1979; Jain, 1988) . We have shown that the pharmacological responses of blood vessels in a growing tumour, Colon 26, differed considerably from the responses of vessels of a similar age which were not associated with neoplastic tissue. We have observed similar pharmacological differences between normal and B16 melanoma neovasculature (unpublished observations) suggesting this response is not a unique property of the Colon 26 tumours. These findings suggest that the nature of the angiogenic stimulus influences the pharmacological behaviour of newly formed blood vessels. The experimental system described here may be of some utility in the search for therapeutically useful, pharmacological differences between normal and tumour vasculature.
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